4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001193125-26-333014
See Remarks sold 12,415 shares at $10.05 ($124,722)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kirn David See Remarks | 2026-08-03 | Sale 10b5-1 | −12,415 | $10.05 | $124,722 | 871,737 | D: show line 1 in the form |
| Open-market sales · 12,415 sh · avg $10.05 · $124,722 | |||||||
Loading xslF345X06/ownership.xml…